Home | Site Index | Contact | Disclaimer     
 

Approved for Marketing



Tjet™ Injector System
marketed by Teva Pharmaceuticals for hGH in USA



Elestrin™ estradiol gel
Marketed by Azur Pharma in the USA



Medi-Jector VISION®
needle-free device for use with insulin



ZomaJet® 2 Vision
marketed by Ferring for hGH in Europe and Asia



Twin-Jector® EZ II
marketed by JCR Pharmaceuticals Co. Ltd. for hGH in Japan

 

 

 

 

 

Improving Pharmaceuticals Through
Advanced Drug Delivery Systems

 

Antares Pharma is committed to developing and commercializing novel therapeutic products utilizing our unique, advanced drug delivery systems. Our products are patient focused: they typically improve safety and efficacy, reduce side effects and enable us to deliver a lower dose. Our advanced drug delivery systems are also well positioned for “life cycle extension” options. We believe that we offer a distinct value to patients, physicians and our shareholders.

 

 

 

 

 

 

 

 
 

Navigation Main:  Company Overview  |  Corporate  |  Investor Relations  |  Platforms  |  Products / Pipeline  |  Business Development

 

 © 2009 Antares Pharma Inc. - All rights reserved. - design & code © 2009 by res media